
Artificial Coma Medically Induced Coma Market Size
Artificial Coma/Medically Induced Coma Market Research Report: Information By Type (Propofol and Barbiturate), By Application (Status Epilepticus, Stroke, Traumatic Brain Injury, Brain Infections, Drug Overdose, and Others), By Distribution Channel (Hospital Pharmacies and Drug Stores & Retail Pharmacies), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Fo...

Market Summary
Market Trends
Market CAGR for artificial coma/medically induced coma supplements is being driven by the rising infectious and chronic diseases. The prevalence of infectious and chronic diseases like cancer, diabetes, cardiovascular disease, and hypertension is rising. The aging population is also on the rise, as is the demand for anesthetic drugs, which is fueling the growth of the artificial coma market. For instance, in August 2021, scientists from Washington University School of Medicine in St. Louis and the University of Michigan completed a study for anesthetic medications that will enhance clinical results.
In this investigation, anesthetic medications such as intravenous propofol are used. Research and development efforts are concentrated on anesthetic drugs that put patients into a coma during crucial surgical procedures.By 2050, one in four residents of Europe and North America maybe 65 years of age or older, according to the United Nations Department of Economic and Social Affairs.
The number of chronic disorders affecting the elderly has sharply increased due to the prevalence of older individuals, which has also increased the demand for anesthetic medications. The artificial coma/medically induced coma market is expected to develop due to increased demand to lessen discomfort during surgery, advancements in R&D activities in the biotechnology industries, pharmaceuticals and increased operations. The creation of novel pharmaceuticals for the healthcare industry is accelerating the market's expansion.
Additionally, government initiatives for drug approval and the enormous rise in anesthetic pharmaceuticals are the main drivers of the market's expansion. For instance, Desflurane Liquid for Inhalation, the first generic version of Suprane liquid from Baxter Healthcare in the United States, was introduced in January 2019 by Sandoz, a branch of Novartis. It is utilized to control artificial coma in individuals undergoing surgery. According to an article in Neurology India, the annual incidence of stroke in Asia ranged from 116 to 483/100,000. Stroke cases among younger people have grown significantly, with more severe physical effects.
At the same time, traumatic brain injury is the main factor in brain tissue deterioration. In India, the incidence is three times higher than the global average (13.3 per 100,000). Because of this, the number of procedures performed rises, which is projected to fuel the expansion of the artificial coma industry. Thus, driving the artificial coma/medically induced coma market revenue.
Artificial Coma Medically Induced Coma Market Market Drivers
Market Segment Insights
Artificial coma/medically induced coma Type Insights
Based on type, the Artificial Coma/Medically Induced Coma Market segmentation includes propofol and barbiturate. The propofol segment dominated the market, accounting for 58% of market revenue. The number of surgical procedures is rising yearly due to increased R&D efforts in the pharmaceutical business. This is happening for various reasons, including the aging population, the rise in chronic illnesses, and the growing acceptance of minimally invasive surgery. A popular anesthetic, propofol is used for many surgical operations, including general anesthesia, sedation, and procedural sedation. It is often used in large quantities when a new medicine is introduced.
Artificial coma/medically induced coma Application Insights
The Artificial Coma/Medically Induced Coma Market segmentation, based on application, includes status epilepticus, stroke, traumatic brain injury, drug overdose, brain infections, and others. The stroke segment dominated the market. The rise in chronic illnesses, the aging population, lifestyle issues, and the number of people with diabetes at risk for stroke are all expected to fuel market expansion. The average number of stroke cases yearly is 15 million, of which 6 million result in death and 5 million in permanent disability. Due to the absence of awareness and memory of the stroke caution signs and symptoms, this is crucial.
Artificial coma/medically induced coma Distribution channel Insights
Based on distribution channels, the Artificial Coma/Medically Induced Coma Market segmentation includes hospital pharmacies and drug stores & retail pharmacies. The hospital pharmacies generated the most income (70.4%). According to forecasts, the rise in the geriatric population, the prevalence of chronic diseases, the frequency of lifestyle disorders, and the number of people with diabetes who have suffered strokes would all contribute to the market's expansion. A stroke affects around 15 million people annually, 6 million perish, and 5 million suffer a lifelong disability.
Due to a lack of information and memory of the stroke warning signs and symptoms, this is crucial.
Figure 1: Artificial Coma/Medically Induced Coma Market, by Distribution channel, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Regional Insights
By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. The North American artificial coma/medically induced coma market will dominate this market; Longer-term medically induced comas may now be safely induced and maintained because of developments in medical technology like ventilators and brain monitoring. This has made a larger range of individuals and illnesses eligible to use medically induced coma.
Further, the major countries studied in the market report are The US, Canada, China, Japan, German, France, the UK, Italy, Spain, India, Australia, South Korea, and Brazil.
Figure 2: ARTIFICIAL COMA/MEDICALLY INDUCED COMA MARKET SHARE BY REGION 2022 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Europe has the second-largest market share for Artificial coma/medically induced coma. The advantages of medically induced coma, such as its capacity to shield the brain from more harm and to let the body recuperate, are being recognized by healthcare experts in Europe more and more. This results in more patients using medically induced coma more frequently. Furthermore, the German Artificial coma/medically induced coma market dominated, while the UK Artificial coma/medically induced coma market grew fastest in Europe.
From 2023 to 2032, the Asia-Pacific Artificial coma/medically induced coma Market will develop at the quickest CAGR. Asia Pacific is experiencing a rise in surgical operations due to various causes, including an increased prevalence of chronic illnesses, an aging population, and the growing acceptance of minimally invasive techniques. A medically induced coma is necessary for several surgical operations, such as brain surgery. Furthermore, China's Artificial coma/medically induced coma market had the highest market share. In contrast, the Asia-Pacific region's Artificial coma/medically induced coma market in India was the one that was growing the quickest.
Key Players and Competitive Insights
Leading market companies are extensively spending R&D on increasing their product lines, which will help the Artificial coma/medically induced coma market grow even more. Important market developments include contractual agreements, new product releases, acquisitions and mergers, greater investments, and collaboration with other organizations. The Artificial coma/medically induced coma industry must produce cost-effective merchandise to flourish and thrive in a more competitive and increasing market climate.
Manufacturing locally to reduce operating costs is an effective business strategy manufacturers use in the worldwide Artificial coma/medically induced coma industry to serve clients and expand the market sector. The Artificial coma/medically induced coma industry has provided some of the most important benefits recently. PAION AG , Sandoz; and other major competitors in the Artificial coma/medically induced coma market are seeking to improve market demand by investing in R&D efforts.
A publicly traded specialty pharmaceutical company, PAION AG, offers cutting-edge medications for hospital-based sedation, anesthesia, and critical care services. Remimazolam, an intravenous, ultra-short-acting, and controlled benzodiazepine sedative/anesthetic, is the main ingredient of PAION. Remimazolam has partners in several non-European countries. Remimazolam is authorized in the United States, the EU/EEA/UK, and China, and general anesthesia in Japan and South Korea for procedural sedation. In June 2021, The UK MHRA has authorised Byfavo(R) (remimazolam besylate) in adults for procedural sedation, according to the specialised pharmaceutical firm PAION AG. An ultra-short acting intravenous benzodiazepine sedative/anesthetic is called Byfavo(R).
The choice was made when the European Commission gave its consent to the EU (together with EEA nations) in March 2021.
The leader in biosimilars and generic drugs is Sandoz. Their goal is to develop cutting-edge methods that will make high-quality medication more accessible to people worldwide. Their corporate goal is to become the world's most prestigious and successful generics firm. Their worldwide portfolio, comprising over 1000 compounds and covering a wide spectrum of therapeutic areas, is expected to generate $9.2 billion in sales by 2022.
Their extensive selection results in large and recurring savings for patients and payors, ensuring the viability of healthcare systems in the face of severe financial demands and freeing up cash for cutting-edge medications.In January 2019, Desflurane Liquid for Inhalation is the first Suprane liquid generic made available in the United States by Sandoz, a part of Novartis. It is utilized to control artificial coma in individuals undergoing surgery.
Industry Developments
Market Segmentation
Artificial Coma/Medically Induced Coma Type Outlook
- Propofol
- Barbiturate
Artificial Coma/Medically Induced Coma Regional Outlook
- US
- Canada
Artificial Coma/Medically Induced Coma Application Outlook
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
Artificial Coma/Medically Induced Coma Distribution Channel Outlook
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
Report Scope
Report Attribute/Metric | Details |
Market Size 2024 | 0.85 (USD Billion) |
Market Size 2025 | 0.88 (USD Billion) |
Market Size 2035 | 1.24 (USD Billion) |
Compound Annual Growth Rate (CAGR) | 3.50% (2025 - 2035) |
Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
Base Year | 2024 |
Market Forecast Period | 2025 - 2035 |
Historical Data | 2020 - 2024 |
Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
Segments Covered | Type, Application, Distribution Channel, and Region |
Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
Countries Covered | The US, Canada, German, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
Key Companies Profiled | Piramal Group, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Fresenius Se & Co Kgaa, Astrazeneca Plc, Dr. Reddy’s Laboratory, Pfizer Inc., Viatris Inc. (Mylan N.V), B.Braun Melsungen Ag, Baxter International Inc. |
Key Market Opportunities | · Advancement in technology |
Key Market Dynamics | · Increase in chronic diseases |
Market Highlights
Author
Latest Comments
This is a great article! Really helped me understand the topic better.
Thanks for sharing this. I’ve bookmarked it for later reference.
FAQs
How much is the artificial coma/medically induced coma market?
The Artificial Coma/Medically Induced Coma Market size was valued at USD 0.8 Billion in 2022.
What is the growth rate of the artificial coma/medically induced coma market?
The global market is projected to grow at a CAGR of 3.50% during the forecast period, 2023-2032.
Which region held the largest market share in the artificial coma/medically induced coma market?
North America had the largest share in the global market
Who are the key players in the artificial coma/medically induced coma market?
The key players in the market are Piramal Group, Teva Pharmaceutical Industries Ltd., Hikma Pharmaceuticals, Fresenius Se & Co Kgaa, Astrazeneca Plc, Dr. Reddy’s Laboratory, Pfizer Inc., Viatris Inc. (Mylan N.V), B.Braun Melsungen Ag, Baxter International Inc.
5. Which type led the artificial coma/medically induced coma market?
The Propofol dominated the market in 2022.
Which distribution channel had the largest market share in the artificial coma/medically induced coma market?
The Hospital Pharmacies had the largest share in the global market.
-
Table of Contents
-
Executive Summary
-
Market Introduction
- Definition
-
Scope of the Study
- Research Objective
- Assumptions
- Limitations
-
Research Methodology
- Overview
- Data Mining
- Secondary Research
-
Primary Research
- Primary Interviews and Information Gathering Process
- Breakdown of Primary Respondents
- Forecasting Model
-
Market Size Estimation
- Bottom-up Approach
- Top-Down Approach
- Data Triangulation
- Validation
-
MARKET DYNAMICS
- Overview
- Drivers
- Restraints
- Opportunities
-
MARKET FACTOR ANALYSIS
- Value Chain Analysis
-
Porter’s Five Forces Analysis
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of New Entrants
- Threat of Substitutes
- Intensity of Rivalry
-
COVID-19 Impact Analysis
- Market Impact Analysis
- Regional Impact
- Opportunity and Threat Analysis
-
GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE
- Overview
- Propofol
- Barbiturate
-
GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION
- Overview
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
-
GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL
- Overview
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
-
GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY REGION
- Overview
-
North America
- US
- Canada
-
Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
-
Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia-Pacific
-
Rest of the World
- Middle East
- Africa
- Latin America
-
Competitive Landscape
- Overview
- Competitive Analysis
- Market Share Analysis
- Major Growth Strategy in the Global Artificial coma / medically induced coma Market,
- Competitive Benchmarking
- Leading Players in Terms of Number of Developments in the Global Artificial coma / medically induced coma Market,
-
Key developments and Growth Strategies
- New Product Launch/Service Deployment
- Merger & Acquisitions
- Joint Ventures
-
Major Players Financial Matrix
- Sales & Operating Income, 2022
- Major Players R&D Expenditure. 2022
-
COMPANY PROFILES
-
PIRAMAL GROUP
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
-
TEVA PHARMACEUTICAL INDUSTRIES LTD.
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
-
HIKMA PHARMACEUTICALS
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
-
FRESENIUS SE & CO KGAA
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
-
ASTRAZENECA PLC
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
-
DR. REDDY’S LABORATORY
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
-
PFIZER INC.
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
-
VIATRIS INC. (MYLAN N.V)
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
-
B.BRAUN MELSUNGEN AG
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
-
BAXTER INTERNATIONAL INC.
- Company Overview
- Financial Overview
- Products Offered
- Key Developments
- SWOT Analysis
- Key Strategies
-
PIRAMAL GROUP
-
APPENDIX
- References
- Related Reports
-
-
List of Tables and Figures
- LIST OF TABLES
- TABLE 1 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SYNOPSIS, 2018-2032
- TABLE 2 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, ESTIMATES & FORECAST, 2018-2032 (USD BILLION)
- TABLE 3 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 4 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 5 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 6 NORTH AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 7 NORTH AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 8 NORTH AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 9 US: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 10 US: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 11 US: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 12 CANADA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 13 CANADA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 14 CANADA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 15 EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 16 EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 17 EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 18 GERMANY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 19 GERMANY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 20 GERMANY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 21 FRANCE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 22 FRANCE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 23 FRANCE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 24 ITALY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 25 ITALY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 26 ITALY: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 27 SPAIN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 28 SPAIN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 29 SPAIN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 30 UK: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 31 UK: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 32 UK: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 33 REST OF EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 34 REST OF EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 35 REST OF EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 36 ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 37 ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 38 ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 39 JAPAN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 40 JAPAN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 41 JAPAN: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 42 CHINA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 43 CHINA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 44 CHINA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 45 INDIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 46 INDIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 47 INDIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 48 AUSTRALIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 49 AUSTRALIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 50 AUSTRALIA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 51 SOUTH KOREA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 52 SOUTH KOREA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 53 SOUTH KOREA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 54 REST OF ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 55 REST OF ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 56 REST OF ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 57 REST OF THE WORLD: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 58 REST OF THE WORLD: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 59 REST OF THE WORLD: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 60 MIDDLE EAST: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 61 MIDDLE EAST: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 62 MIDDLE EAST: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 63 AFRICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 64 AFRICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 65 AFRICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION)
- TABLE 66 LATIN AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY TYPE, 2018-2032 (USD BILLION)
- TABLE 67 LATIN AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY APPLICATION, 2018-2032 (USD BILLION)
- TABLE 68 LATIN AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, BY DISTRIBUTION CHANNEL, 2018-2032 (USD BILLION) LIST OF FIGURES
- FIGURE 1 RESEARCH PROCESS
- FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET
- FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET
- FIGURE 4 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY TYPE, 2022
- FIGURE 5 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY APPLICATION, 2022
- FIGURE 6 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY DISTRIBUTION CHANNEL, 2022
- FIGURE 7 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY REGION, 2022
- FIGURE 8 NORTH AMERICA: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY REGION, 2022
- FIGURE 9 EUROPE: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY REGION, 2022
- FIGURE 10 ASIA-PACIFIC: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY REGION, 2022
- FIGURE 11 REST OF THE WORLD: ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET, SHARE (%), BY REGION, 2022
- FIGURE 12 GLOBAL ARTIFICIAL COMA / MEDICALLY INDUCED COMA MARKET: COMPANY SHARE ANALYSIS, 2022 (%)
- FIGURE 13 PIRAMAL GROUP: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 14 PIRAMAL GROUP: SWOT ANALYSIS
- FIGURE 15 TEVA PHARMACEUTICAL INDUSTRIES LTD.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 16 TEVA PHARMACEUTICAL INDUSTRIES LTD.: SWOT ANALYSIS
- FIGURE 17 HIKMA PHARMACEUTICALS: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 18 HIKMA PHARMACEUTICALS: SWOT ANALYSIS
- FIGURE 19 FRESENIUS SE & CO KGAA: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 20 FRESENIUS SE & CO KGAA: SWOT ANALYSIS
- FIGURE 21 ASTRAZENECA PLC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 22 ASTRAZENECA PLC.: SWOT ANALYSIS
- FIGURE 23 DR. REDDY’S LABORATORY: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 24 DR. REDDY’S LABORATORY: SWOT ANALYSIS
- FIGURE 25 PFIZER INC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 26 PFIZER INC.: SWOT ANALYSIS
- FIGURE 27 VIATRIS INC. (MYLAN N.V): FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 28 VIATRIS INC. (MYLAN N.V): SWOT ANALYSIS
- FIGURE 29 B.BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 30 B.BRAUN MELSUNGEN AG: SWOT ANALYSIS
- FIGURE 31 BAXTER INTERNATIONAL INC.: FINANCIAL OVERVIEW SNAPSHOT
- FIGURE 32 BAXTER INTERNATIONAL INC.: SWOT ANALYSIS
Market Segmentation Tab
Artificial Coma/Medically Induced Coma Type Outlook (USD Billion, 2018-2032)
- Propofol
- Barbiturate
Artificial Coma/Medically Induced Coma by Application Outlook (USD Billion, 2018-2032)
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
Artificial Coma/Medically Induced Coma Distribution Channel Outlook (USD Billion, 2018-2032)
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
Artificial Coma/Medically Induced Coma Regional Outlook (USD Billion, 2018-2032)
- North America Outlook (USD Billion, 2018-2032)
- North America Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- North America Artificial Coma/Medically Induced Coma by application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- North America Artificial Coma/Medically Induced Coma by Type
- North America Artificial Coma/Medically Induced Coma Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- US Outlook (USD Billion, 2018-2032)
- US Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- US Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- US Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- CANADA Outlook (USD Billion, 2018-2032)
- CANADA Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- CANADA Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- CANADA Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Europe Outlook (USD Billion, 2018-2032)
- Europe Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Europe Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Europe Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Germany Outlook (USD Billion, 2018-2032)
- Germany Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Germany Artificial Coma/Medically Induced Coma by Application Outlook
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Germany Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- France Outlook (USD Billion, 2018-2032)
- France Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- France Artificial Coma/Medically Induced Coma by Application Outlook
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- France Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- UK Outlook (USD Billion, 2018-2032)
- UK Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- UK Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- UK Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- ITALY Outlook (USD Billion, 2018-2032)
- ITALY Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- ITALY Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- ITALY Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- SPAIN Outlook (USD Billion, 2018-2032)
- Spain Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- SPAIN Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Spain Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Rest Of Europe Outlook (USD Billion, 2018-2032)
- Rest Of Europe Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Rest Of Europe Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- REST OF EUROPE Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Asia-Pacific Outlook (USD Billion, 2018-2032)
- Asia-Pacific Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Asia-Pacific Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Asia-Pacific Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- China Outlook (USD Billion, 2018-2032)
- China Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- China Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- China Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Japan Outlook (USD Billion, 2018-2032)
- Japan Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Japan Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Japan Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- India Outlook (USD Billion, 2018-2032)
- India Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- India Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- India Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Australia Outlook (USD Billion, 2018-2032)
- Australia Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Australia Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Australia Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Rest of Asia-Pacific Outlook (USD Billion, 2018-2032)
- Rest of Asia-Pacific Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Rest of Asia-Pacific Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Rest of Asia-Pacific Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Rest of the World Outlook (USD Billion, 2018-2032)
- Rest of the World Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Rest of the World Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Rest of the World Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Middle East Outlook (USD Billion, 2018-2032)
- Middle East Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Middle East Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Middle East Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Africa Outlook (USD Billion, 2018-2032)
- Africa Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Africa Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Africa Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Latin America Outlook (USD Billion, 2018-2032)
- Latin America Artificial Coma/Medically Induced Coma by Type
- Propofol
- Barbiturate
- Latin America Artificial Coma/Medically Induced Coma by Application
- Status Epilepticus
- Stroke
- Traumatic Brain Injury
- Brain Infections
- Drug Overdose
- Others
- Latin America Artificial Coma/Medically Induced Coma by Distribution Channel
- Hospital Pharmacies
- Drug Stores & Retail Pharmacies
- Latin America Artificial Coma/Medically Induced Coma by Type
- Africa Artificial Coma/Medically Induced Coma by Type
- Middle East Artificial Coma/Medically Induced Coma by Type
- Rest of the World Artificial Coma/Medically Induced Coma by Type
- Rest of Asia-Pacific Artificial Coma/Medically Induced Coma by Type
- Australia Artificial Coma/Medically Induced Coma by Type
- India Artificial Coma/Medically Induced Coma by Type
- Japan Artificial Coma/Medically Induced Coma by Type
- China Artificial Coma/Medically Induced Coma by Type
- Asia-Pacific Artificial Coma/Medically Induced Coma by Type
- Rest Of Europe Artificial Coma/Medically Induced Coma by Type
- Spain Artificial Coma/Medically Induced Coma by Type
- ITALY Artificial Coma/Medically Induced Coma by Type
- UK Artificial Coma/Medically Induced Coma by Type
- France Artificial Coma/Medically Induced Coma by Type
- Germany Artificial Coma/Medically Induced Coma by Type
- Europe Artificial Coma/Medically Induced Coma by Type
- CANADA Artificial Coma/Medically Induced Coma by Type
- US Artificial Coma/Medically Induced Coma by Type

Free Sample Request
Kindly complete the form below to receive a free sample of this Report
Customer Strories
“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”
Leave a Comment